Tech-enabled provider of asset integrity inspection, engineering consulting and geospatial services for industrial infrastructure.
Tech-enabled provider of asset integrity inspection, engineering consulting and geospatial services for industrial infrastructure.
Much of the work is repeat inspection of pipelines, refineries and plants required by regulators and insurers, billed on hours worked or under multi-year master service agreements. Plant maintenance shutdowns create seasonal peaks. The consulting and geospatial lines were added through acquisitions.
In one line: An industrial testing, inspection and certification (TIC) services company.
Moat: narrow (regulatory licence, customer qualification, scale). Compliance-driven, recurring inspection contracts and a large certified technician workforce create barriers to entry.
Employees: 12,760
Size TIC Solutions (TIC) is a United States Industrials company (Miscellaneous Commercial Services) with a market value of $2.15B, the 1729th largest of 3,085 United States companies the cockpit tracks. Shares closed at $9.83 on 18 Nov 2026.
Performance Over six months the shares gained 14.4%, against -4.4% for the median peer and -2.2% for the United States market (cap-weighted) — 5th highest of 21 in its peer set.
Growth Revenue grew 39.5% over the last twelve months (peer median +17.6%); the operating margin is -0.7% (peer median 15.5%).
Valuation It trades at 1.6× enterprise value to sales against a peer median of 3.4× (6th cheapest of 21).
Capital Return on invested capital runs 10.4 points below its cost of capital (10.1% WACC).
Backlog Backlog (remaining performance obligations) was $1.30B at 30 Sep 2026, up 30% on a year earlier — 0.6 years of trailing revenue. Backlog detail →
Short interest Short interest is 17.7% of the free float (30 Oct 2026).
Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | |
|---|---|---|---|---|
| Revenue | $2.22B | $1.53B | $1.10B | $0 |
| Revenue growth | — | +39% | — | — |
| Gross profit | $634M | $339M | $220M | $0 |
| EBITDA | $234M | $187M | $87.1M | -$1.28M |
| Net income | -$113M | -$86.5M | -$121M | $14.0M |
| Free cash flow | $59.1M | $61.3M | -$4.51M | $8.10M |
| Capital expenditure | $51.8M | $33.8M | $27.6M | $0 |
| Total debt | $1.71B | $1.71B | $813M | $0 |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g |
|---|---|---|---|---|---|---|
| TIC Solutions TIC | $2.15B | +14% | +39% | -1% | 1.6× | 32.6% |
| Bureau Veritas BVI.PA | $14.8B | +17% | +2% | 15% | 2.4× | 8.3% |
| Team 4967.TW | $673M | -13% | +91% | 35% | 0.7× | n/a |
| Mistras MG | $643M | +19% | +5% | 7% | 1.1× | 8.1% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | TIC | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +9.7% | -1.1% | 4th highest of 21 |
| 6-month return | +14.4% | -4.4% | 5th highest of 21 |
| Distance from 52-week high | -17.1% | -30.5% | 7th highest of 21 |
| Revenue growth (TTM) | +39.5% | +17.6% | 4th highest of 20 |
| Operating margin | -0.7% | 15.5% | 2nd lowest of 21 |
| EV / Sales | 1.6× | 3.4× | 6th cheapest of 21 |
| Growth the price implies (Req g, 7 yrs) | 32.6% | 5.4% | 3rd most demanding of 15 |
| ROIC minus cost of capital | -10.4 pp | +1.3 pp | 2nd lowest of 19 |
| EV / EBITDA | 15.6× | 10.8× | 4th most expensive of 12 |
| Net debt / EBITDA | 6.5× | 0.1× | most indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| TIC Solutions TIC | United States | $2.15B | +14% | +39% | -1% | 1.6× | 32.6% | n/a |
| Heron Neutron Medical 7799.TW | Taiwan | $2.15B | +56% | n/a | -5,319% | 6,358.6× | n/a | n/a |
| Ardentec 3264.TWO | Taiwan | $2.17B | -26% | +32% | 30% | 4.7× | n/a | n/a |
| Sigurd Microelectronics 6257.TW | Taiwan | $2.10B | -28% | +18% | 24% | 3.5× | n/a | n/a |
| Biocytogen Pharmaceuticals (Beijing) 688796.SS | China | $2.09B | -33% | +40% | 24% | 8.3× | 31.0% | +41.1% |
| Suzhou Nanomicro Technology 688690.SS | China | $2.08B | -1% | +26% | 25% | 11.9× | 33.2% | +35.2% |
| International Gemological Institute IGIL.NS | India | $2.05B | +33% | +21% | 58% | 12.9× | 16.3% | +37.6% |
| Firstsource Solutions FSL.NS | India | $2.04B | +13% | +20% | 12% | 2.0× | 19.2% | +13.5% |
| Sagility SAGILITY.NS | India | $2.26B | +7% | +28% | 18% | 2.6× | 11.2% | +19.5% |
| Hui Lyu Ecological Technology Groups 001267.SZ | China | $2.28B | -68% | +90% | 10% | 7.0× | n/a | n/a |
| KWS SAAT SE & Co KGaA KWS.DE | Germany | $2.30B | -11% | -1% | 13% | 1.4× | -6.0% | +4.4% |
| China Automotive Engineering Research Institute 601965.SS | China | $2.31B | -11% | +12% | 24% | 3.3× | -4.7% | +7.9% |
| CECEP Environmental Protection 300140.SZ | China | $2.37B | -23% | -2% | 23% | 4.2× | -1.9% | +26.0% |
| Shanghai GenTech 688596.SS | China | $2.37B | +4% | +4% | 2% | 3.4× | n/a | n/a |
| Syngene International SYNGENE.NS | India | $1.88B | -8% | -6% | 13% | 5.0× | 36.4% | +11.4% |
| V2X VVX | United States | $2.45B | +9% | +13% | 4% | 0.7× | -0.5% | +26.3% |
| Jiangsu Guotai International 002091.SZ | China | $1.87B | -15% | +7% | 6% | 0.2× | -21.2% | +5.5% |
| Insperity NSP | United States | $1.86B | +55% | +2% | 0% | 0.2× | 19.4% | +9.7% |
| Visional 4194.T | Japan | $2.50B | +33% | +24% | 25% | 3.2× | -2.1% | +28.2% |
| Jiangsu Boqian New Materials Stock 605376.SS | China | $2.52B | -46% | +76% | 20% | 9.7× | n/a | n/a |
| Prosegur Compania de Seguridad PSG.MC | Spain | $1.82B | +10% | +4% | 6% | 0.6× | -3.7% | +6.7% |
TIC Solutions reported $1.30B of remaining performance obligations at 30 Sep 2026, up 30% from a year earlier and up 8% from the previous quarter. That is 0.6 years of trailing revenue already under contract. Book-to-bill last quarter: 1.16.